Literature DB >> 23737477

Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology.

Tanweer Zaidi1, Tauqeer Zaidi, Pauline Yoong, Gerald B Pier.   

Abstract

PURPOSE: Community-associated methicillin-resistant Staphylococcus aureus strains expressing Panton-Valentine leukocidin (PVL) are associated with severe skin and soft tissue infections, necrotizing pneumonia, and eye infections. We determined PVL's toxicity on infected mouse and cultured human corneal epithelial cells and the role of PVL and antibody to PVL in pathogenesis of murine keratitis.
METHODS: Cytotoxicity on corneas and corneal epithelial cells was evaluated by LDH assays. Scratched corneas of female A/J mice were inoculated with approximately 10⁷ CFU/eye of either WT S. aureus, isogenic ΔPVL, or strains overproducing PVL. Antibodies to PVL or control sera were topically applied to infected corneas 0, 24, and 32 hours postinfection, corneas scored for pathology and tissue levels of S. aureus were determined.
RESULTS: PVL expression augmented the cytotoxicity of S. aureus on infected mouse corneas and human cultured corneal epithelial cells. Variable effects on leukocyte recruitment, pathogenesis, and immunity were obtained in the in vivo studies. Inactivation of PVL in USA300 strains caused reduced pathology and bacterial counts. Results were variable when comparing WT and ΔPVL USA400 strains, while USA400 strains overproducing PVL caused increased bacterial burdens. Topical treatment with polyclonal antibody to PVL yielded significant reductions in corneal pathology and bacterial CFU in corneas infected with USA300 strains, whereas effects were inconsistent in eyes infected with USA400 strains.
CONCLUSIONS: PVL enhanced the virulence of a subset of MRSA strains in a keratitis model. Coupled with a variable effect of antibody treatment, it appears that PVL plays an inconsistent role in pathogenesis and immunity to S. aureus corneal infection.

Entities:  

Keywords:  MRSA; PVL; antibody; keratitis

Mesh:

Substances:

Year:  2013        PMID: 23737477      PMCID: PMC3700385          DOI: 10.1167/iovs.13-11701

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  47 in total

1.  Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene.

Authors:  Paula Peyrani; Marty Allen; Timothy L Wiemken; Nadia Z Haque; Marcus J Zervos; Kimbal D Ford; Ernesto G Scerpella; Julie E Mangino; Daniel H Kett; Julio A Ramirez
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

2.  Composition of staphylococcal bi-component toxins determines pathophysiological reactions.

Authors:  B König; G Prévost; W König
Journal:  J Med Microbiol       Date:  1997-06       Impact factor: 2.472

Review 3.  Role of innate and adaptive immunity in the pathogenesis of keratitis.

Authors:  Linda D Hazlett
Journal:  Ocul Immunol Inflamm       Date:  2005 Apr-Jun       Impact factor: 3.070

4.  Effect of aminoglycosides (sub-MICs) on adherence of coagulase-negative Staphylococci to intraocular lens surface.

Authors:  G Chisari; S Accossano; M Reibaldi
Journal:  J Chemother       Date:  2002-12       Impact factor: 1.714

5.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

Review 6.  Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Michael Otto
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

7.  Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis.

Authors:  A Thakur; M Xue; F Stapleton; A R Lloyd; D Wakefield; M D P Willcox
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

8.  Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005.

Authors:  Penny A Asbell; Daniel F Sahm; Mary Shaw; Deborah C Draghi; Nina P Brown
Journal:  J Cataract Refract Surg       Date:  2008-05       Impact factor: 3.351

9.  Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8.

Authors:  B König; M Köller; G Prevost; Y Piemont; J E Alouf; A Schreiner; W König
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

Review 10.  Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis.

Authors:  Patrick M Schlievert; Kristi L Strandberg; Ying-Chi Lin; Marnie L Peterson; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

View more
  16 in total

Review 1.  Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.

Authors:  Victoria S Chang; Deepinder K Dhaliwal; Leela Raju; Regis P Kowalski
Journal:  Cornea       Date:  2015-06       Impact factor: 2.651

Review 2.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

3.  A Mouse Model for Ocular Surface Staphylococcus aureus Infection.

Authors:  Zhiyong Zhang; Osama Abdel-Razek; Guirong Wang
Journal:  Curr Protoc Mouse Biol       Date:  2017-03-02

4.  In Vivo Role of TLR2 and MyD88 Signaling in Eliciting Innate Immune Responses in Staphylococcal Endophthalmitis.

Authors:  Deepa Talreja; Pawan Kumar Singh; Ashok Kumar
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-12       Impact factor: 4.799

5.  Virulence Genes of Staphylococcus aureus Associated With Keratitis, Conjunctivitis, and Contact Lens-Associated Inflammation.

Authors:  Madeeha Afzal; Ajay Kumar Vijay; Fiona Stapleton; Mark Willcox
Journal:  Transl Vis Sci Technol       Date:  2022-07-08       Impact factor: 3.048

6.  Staphylococcus aureus Leukocidin A/B (LukAB) Kills Human Monocytes via Host NLRP3 and ASC when Extracellular, but Not Intracellular.

Authors:  Jason H Melehani; David B A James; Ashley L DuMont; Victor J Torres; Joseph A Duncan
Journal:  PLoS Pathog       Date:  2015-06-12       Impact factor: 6.823

7.  A Mouse Model of Multi-Drug Resistant Staphylococcus aureus-induced Ocular Disease.

Authors:  Nicole M Broekema; Inna V Larsen; Erika S Naruzawa; Marcin Filutowicz; Aaron W Kolb; Leandro B C Teixeira; Curtis R Brandt
Journal:  J Ocul Biol       Date:  2016-11-10

8.  Ex vivo rabbit and human corneas as models for bacterial and fungal keratitis.

Authors:  Abigail Pinnock; Nagaveni Shivshetty; Sanhita Roy; Stephen Rimmer; Ian Douglas; Sheila MacNeil; Prashant Garg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-14       Impact factor: 3.117

9.  Ocular bacterial infections at Quiha Ophthalmic Hospital, Northern Ethiopia: an evaluation according to the risk factors and the antimicrobial susceptibility of bacterial isolates.

Authors:  Mebrahtu Teweldemedhin; Muthupandian Saravanan; Araya Gebreyesus; Dawit Gebreegziabiher
Journal:  BMC Infect Dis       Date:  2017-03-14       Impact factor: 3.090

Review 10.  Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy.

Authors:  M Javad Aman; Rajan P Adhikari
Journal:  Toxins (Basel)       Date:  2014-03-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.